134 related articles for article (PubMed ID: 16734210)
1. [Anti-ErbB targeted therapy and urothelial tumors].
Amsellem-Ouazana D; Goldwasser F; Bieche I; Lidereau R; Zerbib M
Prog Urol; 2005 Dec; 15(6 Suppl 1):1229-35. PubMed ID: 16734210
[No Abstract] [Full Text] [Related]
2. p53 and treatment of bladder cancer.
Cote RJ; Esrig D; Groshen S; Jones PA; Skinner DG
Nature; 1997 Jan; 385(6612):123-5. PubMed ID: 8990112
[No Abstract] [Full Text] [Related]
3. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.
Chen F; Zhang G; Cao Y; Hessner MJ; See WA
J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors of urinary bladder carcinoma].
vom Dorp F; Jaeger T; Schmidt K; Siffert W; Rübben H
Urologe A; 2007 Sep; 46(9):1151. PubMed ID: 17641868
[No Abstract] [Full Text] [Related]
5. Recent advances in the study of molecular biology of bladder cancer in China.
Gu F
Chin Med J (Engl); 1996 Feb; 109(2):126-9. PubMed ID: 8758335
[No Abstract] [Full Text] [Related]
6. [In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
Kunze D; Füssel S; Meye A; Wuttig D; Krämer K; Kotzsch M; Toma M; Schwenzer B; Kausch I; Jocham D; Hakenberg OW; Grimm MO; Wirth MP
Urologe A; 2007 Sep; 46(9):1289. PubMed ID: 17665160
[No Abstract] [Full Text] [Related]
7. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
8. [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].
Cussenot O; Davin JL
Prog Urol; 2003 Nov; 13(5 Suppl 2):1233. PubMed ID: 15816391
[No Abstract] [Full Text] [Related]
9. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
Chen F; Zhang G; Cao Y; Payne R; See WA
J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
[TBL] [Abstract][Full Text] [Related]
10. Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma.
Pinciroli P; Won H; Iyer G; Canevari S; Colecchia M; Giannatempo P; Raggi D; Pierotti MA; De Braud FG; Solit DB; Rosenberg JE; Berger MF; Necchi A
Clin Genitourin Cancer; 2016 Feb; 14(1):e81-90. PubMed ID: 26371421
[No Abstract] [Full Text] [Related]
11. Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.
Palma N; Morris JC; Ali SM; Ross JS; Pal SK
Eur Urol; 2015 Jul; 68(1):168-70. PubMed ID: 25766722
[No Abstract] [Full Text] [Related]
12. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
13. The FISH test for the diagnosis, surveillance, and prognosis of transitional cell carcinoma of the bladder.
Haddad FS
J Med Liban; 2008; 56(4):230-2. PubMed ID: 19115598
[TBL] [Abstract][Full Text] [Related]
14. [Photodynamic therapy for superficial bladder tumors].
Gattegno B; Chopin D
Prog Urol; 2001 Nov; 11(5):1119-24. PubMed ID: 11769076
[No Abstract] [Full Text] [Related]
15. Loss of e-cadherin and retinoblastoma genes in a case of urothelial carcinoma with scrotal metastasis.
Norberg SM; Oros M; Manucha V; Eun D; Bilusic M
Can J Urol; 2015 Apr; 22(2):7755-7. PubMed ID: 25891343
[TBL] [Abstract][Full Text] [Related]
16. High incidence of aneuploidy in low grade urothelial carcinomas.
Alvarez AL
Int J Urol; 2008 Mar; 15(3):279. PubMed ID: 18304233
[No Abstract] [Full Text] [Related]
17. An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.
Scher HI
J Urol; 1994 Nov; 152(5 Pt 1):1652-3. PubMed ID: 7933222
[No Abstract] [Full Text] [Related]
18. Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder.
Sadeghi S; Garcia JA
Semin Oncol; 2012 Oct; 39(5):608-14. PubMed ID: 23040257
[TBL] [Abstract][Full Text] [Related]
19. [Metastases from urothelial carcinoma : future and prospects].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S277-84. PubMed ID: 19070804
[TBL] [Abstract][Full Text] [Related]
20. Targeting Signaling Transduction Pathways in Bladder Cancer.
Abbosh PH; McConkey DJ; Plimack ER
Curr Oncol Rep; 2015 Dec; 17(12):58. PubMed ID: 26472299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
